Overview

             -- Phase 3 MAESTRO-NASH Program Continues to Progress --  -- Jim Daly Added to Board of Directors and Becky Taub Promoted to President of R&D -- -- Madrigal Presentations Selected for the Liver Meeting ®  AASLD 2019 in Boston , November 2019 -- CONSHOHOCKEN, Pa. , Aug.

-- Dr. Taub to present at the 5th Paris NASH Meeting to be held on July 11-12, 2019 -- CONSHOHOCKEN, Pa. , July 11, 2019 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) announced today the promotion of Rebecca Taub , M.D., to the newly created positon of President of Research &

CONSHOHOCKEN, Pa. , July 02, 2019 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) today announced that Jim Daly has been appointed to the Company’s Board of Directors, as a Class I director, effective as of June 27 , 2019.  “We are extremely pleased to have an executive with Jim’s